RESPIRATION is a prestigious journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine, with a commitment to publishing high-quality, peer-reviewed research. Established in 1944 and published by KARGER in Switzerland, this journal has maintained an exemplary impact within the scientific community, currently holding a Q1 ranking in the 2023 category for Pulmonary and Respiratory Medicine, placing it among the top 18% of journals in its field. With an ISSN of 0025-7931 and an E-ISSN of 1423-0356, RESPIRATION provides a platform for researchers and professionals to disseminate original studies, reviews, and clinical cases that shape contemporary understanding and treatment of respiratory diseases. The journal's rigorous standards for publication ensure that it remains a vital resource for the latest innovations and findings. As part of its mission, RESPIRATION seeks to bridge the gap between clinical practice and research, fostering multidisciplinary collaboration and enhancing patient outcomes. The journal is readily accessible, ensuring that vital research reaches a broad audience of healthcare professionals and academic scholars globally.

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE is a leading journal published by THIEME MEDICAL PUBL INC, dedicated to advancing knowledge in the fields of respiratory and critical care medicine. Established in 1994, this esteemed publication has consistently provided a platform for researchers, healthcare professionals, and students to explore cutting-edge findings and comprehensive reviews encompassing both critical care and pulmonary domains. With a commendable impact factor and a 2023 ranking in the Q1 quartile for Critical Care and Intensive Care Medicine, as well as Q2 in Pulmonary and Respiratory Medicine, the journal stands out for its rigorous peer-review process and high-quality content. Although it does not operate under an open access model, its accessibility to various academic institutions ensures a broad reach across the medical community. By disseminating significant research, clinical insights, and critical updates, SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE serves as an essential resource for those aiming to stay at the forefront of their disciplines and enhance patient care outcomes.

Welcome to the Indian Journal of Respiratory Care, a premier platform dedicated to advancing research and clinical practices in the field of respiratory health. Published by JAYPEE BROTHERS MEDICAL PUBLISHERS PVT LTD, this journal has established itself as a crucial resource for researchers, healthcare professionals, and educators since embracing an Open Access model in 2012, ensuring maximum visibility and accessibility of vital research findings. The journal aims to disseminate high-quality articles encompassing a wide range of topics, including but not limited to, respiratory diseases, pulmonary care, and innovative treatment approaches. With its commitment to fostering collaboration and knowledge exchange, the Indian Journal of Respiratory Care is poised to make a significant impact in the ever-evolving landscape of respiratory medicine. As the field continues to grow, this journal serves as an essential touchpoint for those invested in enhancing patient care and outcomes.

Zeitschrift für Pneumologie is a pivotal journal in the field of Pulmonary and Respiratory Medicine, published by Springer Heidelberg, a renowned name in academic publishing. With its ISSN number 2731-7404, it serves as a vital platform for disseminating innovative research and clinical studies relevant to lung health and diseases. This German-based journal aims to bridge the gap between research and practice, encouraging submissions that advance knowledge in respiratory medicine, including pathophysiology, treatment modalities, and patient care strategies. Although currently categorized in the Q4 quartile within its field, its commitment to quality research and emerging insights positions it as an essential resource for researchers, healthcare professionals, and students dedicated to improving respiratory health. The journal operates within the convergence period from 2022 to 2024, promising a dynamic evolution of its content. With limited open access availability, it encourages readership and contribution from its audience, fostering a collaborative academic environment.

Annals of Thoracic and Cardiovascular Surgery is a distinguished open-access journal dedicated to the advancing field of thoracic and cardiovascular surgery. Published by Int Acad Publishing Co Ltd since 2011, this journal has established itself as a vital resource for researchers, healthcare professionals, and students in the fields of cardiology, surgery, gastroenterology, and pulmonary medicine. With an ISSN of 1341-1098 and E-ISSN of 2186-1005, it offers an extensive collection of peer-reviewed research and innovative surgical techniques. The journal is headquartered in Japan and remarkably spans a history of convergence from 1998 to 2024, reflecting its ongoing commitment to publish cutting-edge studies that shape modern surgical practices. Ranking in the Q2 and Q3 quartiles across multiple categories, including surgery and cardiology, the journal's Scopus ranks—#210 in Surgery and #211 in Cardiology—underscore its influence and relevance in the academic landscape. Our aim is to foster a deeper understanding of surgical methodologies, critical care, and clinical advancements, thereby serving as an indispensable resource for the global surgical community.

Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.

Pulmonary Medicine, published by HINDAWI LTD, stands as a prestigious open-access journal since 2010, dedicated to advancing the field of pulmonary and respiratory medicine. Located in Egypt, this journal is indexed with an ISSN of 2090-1836 and an E-ISSN of 2090-1844, and it has attained a commendable Q2 ranking in both the miscellaneous medicine and pulmonary health categories, indicative of its significant impact and quality. With an impressive Scopus ranking of #15 out of 155 in the pulmonary and respiratory medicine category, the journal is positioned in the 90th percentile, highlighting its relevance and contribution to ongoing research. The journal aims to publish high-quality original research, reviews, and clinical studies that address pressing issues in pulmonary health, making it a vital resource for researchers, clinicians, and students seeking to enhance their understanding and practice in respiratory medicine. By embracing an open-access model, Pulmonary Medicine provides a platform for disseminating knowledge, fostering collaboration, and driving innovation within the global scientific community.

THORAX is a premier academic journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine. Published by the esteemed BMJ Publishing Group in the United Kingdom, this journal has been a pivotal resource for researchers and clinicians since its inception in 1946. With a remarkable ranking of #6 out of 155 in its category, THORAX holds a prestigious position within the top 4% of its field, as indicated by its 2023 Q1 quartile classification and a strong Scopus ranking. The journal focuses on publishing high-quality research, reviews, and clinical studies that are essential for understanding respiratory diseases and their management. Although it is not an open-access journal, THORAX provides vital contributions to the academic community, fostering dialogue and innovation in pulmonary medicine. As it approaches its converged years, concluding in 2024, researchers, professionals, and students are encouraged to explore its rich repository of knowledge, while engaging with the most current advancements in the field.

Tuberculosis and Respiratory Diseases is a leading open-access journal published by THE KOREAN ACADEMY OF TUBERCULOSIS & RESPIRATORY DISEASES, dedicated to disseminating knowledge in the fields of infectious diseases and pulmonary medicine. Since its inception in 1980, the journal has undergone significant growth, currently recognized in the elite Q2 category for both Infectious Diseases and Pulmonary and Respiratory Medicine as of 2023. With an impact factor reflecting its esteemed position—ranked 52nd in its category—it serves as a vital resource for researchers and healthcare professionals seeking cutting-edge insights, studies, and advancements in the management and treatment of respiratory diseases, particularly tuberculosis. The journal is committed to providing open access to its content since 2013, ensuring that critical research is available to scholars worldwide, fostering collaboration and innovation in the global fight against respiratory illnesses.

The JOURNAL OF THORACIC IMAGING, published by Lippincott Williams & Wilkins, stands as a pivotal resource in the fields of Pulmonary and Respiratory Medicine as well as Radiology, Nuclear Medicine, and Imaging. With the ISSN 0883-5993 and E-ISSN 1536-0237, this esteemed journal has been providing critical insights and advancements since its inception in 1985, contributing significantly to the ongoing dialogue and research within these disciplines. The journal maintains a commendable position, ranking in the Q2 category in both relevant fields and achieving an impressive Scopus ranking of #46 out of 333 in Radiology and #30 out of 155 in Pulmonary Medicine, showcasing its influence and impact (with particles in the 86th and 80th percentiles, respectively). While the journal is not open access, it continues to disseminate high-quality research that informs clinical best practices and emerging technologies in thoracic imaging. As a leading publication, it serves as an essential tool for researchers, clinicians, and students seeking to stay at the forefront of thoracic health innovations.